Aphakia market to reach $3.37 billion by 2030

Nov. 2, 2026
Aphakia market to reach $3.37 billion by 2030
By AI, Created 00:30 UTC, Nov 02, 2026, AGP -

The global aphakia market is projected to grow from $1.89 billion in 2025 to $3.37 billion by 2030, driven by more cataract surgeries, better intraocular lenses and broader access to eye care. Asia-Pacific is expected to be the fastest-growing region as healthcare spending and ophthalmic technology adoption rise.

Why it matters: - Aphakia is the loss of the eye’s natural lens, which makes clear vision difficult without corrective treatment. - Growth in the market tracks rising demand for vision restoration after cataract surgery and other lens-removal procedures. - The report points to stronger demand for intraocular lenses, customized contact lenses and post-surgical visual rehabilitation.

What happened: - The Business Research Company released its Aphakia Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report estimates the global aphakia market will rise from $1.89 billion in 2025 to $2.12 billion in 2026. - The market is forecast to reach $3.37 billion by 2030. - The company projects a 12.4% CAGR from 2025 to 2026 and a 12.2% CAGR from 2026 to 2030. - The release was issued from London on Nov. 2, 2026.

The details: - Historical growth has been supported by more cataract surgeries, advances in ophthalmic surgical methods, wider access to vision-correcting devices, more eye care clinics and greater awareness of visual impairment treatment. - Future growth is expected to come from technological breakthroughs in intraocular lenses, a shift toward minimally invasive eye surgery and expanded personalized vision correction options. - Pediatric eye care is becoming a bigger focus, along with new investments in eye care infrastructure. - Trends gaining momentum include more intraocular lens implantations, greater use of advanced refractive surgery techniques and broader adoption of customized contact lenses. - The market also includes growing demand for pediatric aphakia treatments and improved visual rehabilitation after surgery. - Cataracts remain the main driver behind aphakia cases because lens removal during cataract surgery creates the condition. - Cataract incidence is rising with aging populations, higher diabetes rates, UV exposure, smoking and nutritional deficiencies. - UK data from May 2024 showed admissions for cataract surgery among people 65 and older in England rose from 516,073 in fiscal 2023 to 581,369 in 2024. - In 2025, North America held the largest share of the aphakia market. - Asia-Pacific is expected to be the fastest-growing regional market in the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report’s update package includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, key technologies and future trends, plus updated graphics and tables. - The report offers a free sample and the full market report online: Download the free sample and View the full report.

Between the lines: - The forecast suggests aphakia is benefiting from the broader growth in cataract care and ophthalmic technology, not just from a standalone disease market. - North America’s current lead reflects established healthcare systems, while Asia-Pacific’s growth outlook points to rising medical access and spending in emerging markets. - The emphasis on personalized and minimally invasive treatment suggests the market is moving toward more specialized and higher-value devices.

What's next: - The next phase of market growth will likely hinge on how quickly eye care providers adopt newer lens technologies and customized correction options. - Regional expansion in Asia-Pacific will depend on infrastructure buildout, technology uptake and access to surgical eye care. - Continued growth in cataract procedures should keep feeding demand for aphakia-related treatments and devices.

The bottom line: - Aphakia is becoming a larger niche within eye care, and the market’s growth is being driven by more cataract surgery, better correction technologies and stronger demand in Asia-Pacific.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Asia Pacific News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Pacific News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.